William H Yang Selected Research

Dry Powder Inhalers

12/2007

Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William H Yang Research Topics

Disease

9	Hereditary Angioedemas 05/2024 - 11/2010
5	Anaphylaxis (Anaphylactic Shock) 01/2022 - 02/2003
5	Asthma (Bronchial Asthma) 12/2021 - 02/2003
5	Urticaria (Hives) 11/2021 - 02/2003
4	Hypersensitivity (Allergy) 01/2022 - 02/2003
4	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 11/2017
3	Angioedema 01/2022 - 02/2003
3	Allergic Rhinitis 12/2021 - 01/2016
2	Neoplasms (Cancer) 01/2023 - 07/2018
2	Chronic Urticaria 11/2021 - 07/2020
2	Abdominal Pain (Pain, Abdominal) 01/2021 - 01/2020
1	Food Hypersensitivity (Food Allergy) 02/2024
1	Milk Hypersensitivity (Milk Allergy) 02/2024
1	Carcinogenesis 01/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2021
1	Back Pain (Backache) 01/2021
1	Diarrhea 01/2021
1	Vomiting 01/2021
1	Hereditary Angioedema Types I and II 11/2018
1	Injection Site Reaction 11/2018
1	Dizziness (Lightheadedness) 11/2018
1	Breast Neoplasms (Breast Cancer) 07/2018
1	Fatigue 09/2017
1	Headache (Headaches) 09/2017
1	Inflammation (Inflammations) 01/2017
1	Serum Sickness 07/2015
1	Wounds and Injuries (Trauma) 01/2014
1	Respiratory Insufficiency (Respiratory Failure) 01/2014
1	Shock 01/2014
1	Sepsis (Septicemia) 01/2014
1	Ascites 01/2014
1	Edema (Dropsy) 11/2010
1	Seasonal Allergic Rhinitis (Hay Fever) 04/2006
1	Immediate Hypersensitivity 02/2003

Drug/Important Bio-Agent (IBA)

5	Monoclonal AntibodiesIBA 05/2024 - 01/2017
5	Omalizumab (Xolair)FDA Link 07/2020 - 09/2012
3	Factor XIIa (Coagulation Factor XIIa)IBA 05/2024 - 01/2022
3	AllergensIBA 02/2024 - 01/2016
3	Plasma KallikreinIBA 01/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2018
3	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 09/2017 - 11/2010
3	TabletsIBA 11/2016 - 04/2006
2	Immunoglobulins (Immunoglobulin)IBA 05/2024 - 01/2022
2	Immunoglobulin E (IgE)IBA 02/2024 - 02/2003
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022 - 01/2016
2	lanadelumabIBA 11/2018 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 02/2003
1	CarcinogensIBA 01/2023
1	A-factor (Streptomyces)IBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	BradykininIBA 01/2022
1	Factor XII (Hageman Factor)IBA 01/2022
1	Histamine Antagonists (Antihistamines)IBA 11/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	AutoantibodiesIBA 11/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2021
1	fenebrutinibIBA 11/2021
1	berotralstatIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 07/2018
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 07/2018
1	EnzymesIBA 07/2018
1	Messenger RNA (mRNA)IBA 07/2018
1	AntibodiesIBA 09/2017
1	SteroidsIBA 09/2012
1	indacaterolIBA 12/2007
1	Beclomethasone (Beclometasone)FDA Link 12/2007
1	Triamcinolone (Aristocort)FDA Link 02/2003
1	Lidocaine (Xylocaine)FDA LinkGeneric 02/2003
1	Methylprednisolone FDA LinkGeneric 02/2003
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2003

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2014
6	Immunotherapy 02/2024 - 04/2006
1	Aftercare (After-Treatment) 07/2020
1	Operative Surgical Procedures 01/2014
1	Intravenous Infusions 01/2014
1	Emergency Treatment 11/2010
1	Dry Powder Inhalers 12/2007
1	Intra-Articular Injections 02/2003